FDA approves neoadjuvant/adjuvant durvalumab for resectable non-small cell lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neoadjuvantadjuvant-durvalumab-resectable-non-small-cell-lung-cancer